BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7408402)

  • 1. Effect of quinine on digoxin kinetics.
    Wandell M; Powell JR; Hager WD; Fenster PE; Graves PE; Conrad KA; Goldman S
    Clin Pharmacol Ther; 1980 Oct; 28(4):425-30. PubMed ID: 7408402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosides.
    Hedman A; Meijer DK
    J Hepatol; 1998 Feb; 28(2):240-9. PubMed ID: 9514537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of quinine on plasma digoxin concentration and renal digoxin clearance.
    Pedersen KE; Lysgaard Madsen J; Klitgaard NA; Kjaer K; Hvidt S
    Acta Med Scand; 1985; 218(2):229-32. PubMed ID: 4061126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R; Nilsson B
    Clin Pharmacol Ther; 1990 Jan; 47(1):20-6. PubMed ID: 2295215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-quinidine-spironolactone interaction.
    Fenster PE; Hager WD; Goodman MM
    Clin Pharmacol Ther; 1984 Jul; 36(1):70-3. PubMed ID: 6734052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin-quinidine interaction in patients with chronic renal failure.
    Fenster PE; Hager WD; Perrier D; Powell JR; Graves PE; Michael UF
    Circulation; 1982 Dec; 66(6):1277-80. PubMed ID: 7139903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.
    Schenck-Gustafsson K; Dahlqvist R
    Br J Clin Pharmacol; 1981 Feb; 11(2):181-6. PubMed ID: 7213521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of digoxin clearance by coadministration of quinidine.
    Ochs HR; Bodem G; Greenblatt DJ
    J Clin Pharmacol; 1981 Oct; 21(10):396-400. PubMed ID: 7309901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinidine reduces biliary clearance of digoxin in man.
    Angelin B; Arvidsson A; Dahlqvist R; Hedman A; Schenck-Gustafsson K
    Eur J Clin Invest; 1987 Jun; 17(3):262-5. PubMed ID: 3113970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of quinidine on digoxin distribution and elimination in guinea pigs.
    Sato J; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1983 Oct; 72(10):1137-41. PubMed ID: 6644558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Eur J Clin Pharmacol; 1992; 42(5):481-5. PubMed ID: 1606994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinidine-digoxin interaction: time course and pharmacokinetics.
    Leahey EB; Bigger JT; Butler VP; Reiffel JA; O'Connell GC; Scaffidi LE; Rottman JN
    Am J Cardiol; 1981 Dec; 48(6):1141-6. PubMed ID: 7304462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin-quinidine interaction Pharmacokinetic evaluation.
    Hager WD; Fenster P; Mayersohn M; Perrier D; Graves P; Marcus FI; Goldman S
    N Engl J Med; 1979 May; 300(22):1238-41. PubMed ID: 431681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of digoxin clearance by activated charcoal.
    Lalonde RL; Deshpande R; Hamilton PP; McLean WM; Greenway DC
    Clin Pharmacol Ther; 1985 Apr; 37(4):367-71. PubMed ID: 3978996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alprazolam on digoxin kinetics and creatinine clearance.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B
    Clin Pharmacol Ther; 1985 Nov; 38(5):595-8. PubMed ID: 2865030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in steady state digoxin pharmacokinetics during quinidine therapy in cardiac patients: influence of plasma quinidine concentration.
    Pedersen KE; Christiansen BD; Klitgaard NA; Nielsen-Kudsk F
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):357-63. PubMed ID: 6880771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes.
    Hedman A; Meijer DK
    J Pharm Sci; 1998 Apr; 87(4):457-61. PubMed ID: 9548899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the interaction between phenytoin and digoxin.
    Rameis H
    Eur J Clin Pharmacol; 1985; 29(1):49-53. PubMed ID: 4054206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-verapamil interaction.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1981 Sep; 30(3):311-6. PubMed ID: 7273594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.